Hsa-miR-149-5p Suppresses Prostate Carcinoma Malignancy by Suppressing RGS17

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.25651787
   PubMed Web of Science ®Google Scholar
• Kimura T, Egawa S. Epidemiology of prostate cancer in Asian countries. Int J Urol. 2018;25(6):524–531.29740894
   PubMed Web of Science ®Google Scholar
• Jeon YJ, Kim OJ, Kim SY, et al. Association of the miR-146a, miR-149, miR-196a2, and miR-499 polymorphisms with ischemic stroke and silent brain infarction risk. Arterioscler Thromb Vasc Biol. 2013;33(2):420–430.23202363
   PubMed Web of Science ®Google Scholar
• Lee KT, Nam JW. Post-transcriptional and translational regulation of mRNA-like long non-coding RNAs by microRNAs in early developmental stages of zebrafish embryos. BMB Rep. 2017;50(4):226–231.28320503
   PubMed Web of Science ®Google Scholar
• Matsushita R, Seki N, Chiyomaru T, et al. Tumour-suppressive microRNA-144-5p directly targets CCNE1/2 as potential prognostic markers in bladder cancer. Br J Cancer. 2015;113(2):282–289.26057453
   PubMed Web of Science ®Google Scholar
• Tsai MM, Wang CS, Tsai CY, et al. MicroRNA-196a/-196b promote cell metastasis via negative regulation of radixin in human gastric cancer. Cancer Lett. 2014;351(2):222–231.24933454
   PubMed Web of Science ®Google Scholar
• Tian X, Wei Z, Wang J, Liu P, Qin Y, Zhong M. MicroRNA-429 inhibits the migration and invasion of colon cancer cells by targeting PAK6/cofilin signaling. Oncol Rep. 2015;34(2):707–714.26058485
   PubMed Web of Science ®Google Scholar
• Xu RD, Feng F, Yu XS, Liu ZD, Lao LF. miR-149-5p inhibits cell growth by regulating TWEAK/Fn14/PI3K/AKT pathway and predicts favorable survival in human osteosarcoma. Int J Immunopathol Pharmacol. 2018;32:2058738418786656.30014744
   PubMed Web of Science ®Google Scholar
• Yang D, Du G, Xu A, Xi X, Li D. Expression of miR-149-3p inhibits proliferation, migration, and invasion of bladder cancer by targeting S100A4. Am J Cancer Res. 2017;7(11):2209–2219.29218245
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu L, Dong Z, Xiong J. miR-149 suppresses human non-small cell lung cancer growth and metastasis by inhibiting the FOXM1/cyclin D1/MMP2 axis. Oncol Rep. 2017;38(6):3522–3530.29130108
   PubMed Web of Science ®Google Scholar
• Rangel J, Nosrati M, Leong SP, et al. Novel role for RGS1 in melanoma progression. Am J Surg Pathol. 2008;32(8):1207–1212.18580492
   PubMed Web of Science ®Google Scholar
• Sierra DA, Gilbert DJ, Householder D, et al. Evolution of the regulators of G-protein signaling multigene family in mouse and human. Genomics. 2002;79(2):177–185.11829488
   PubMed Web of Science ®Google Scholar
• Bodle CR, Mackie DI, Roman DL. RGS17: an emerging therapeutic target for lung and prostate cancers. Future Med Chem. 2013;5(9):995–1007.23734683
   PubMed Web of Science ®Google Scholar
• Sternweis PC, Robishaw JD. Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. J Biol Chem. 1984;259(22):13806–13813.6438083
   PubMed Web of Science ®Google Scholar
• Roman DL, Traynor JR. Regulators of G protein signaling (RGS) proteins as drug targets: modulating G-protein-coupled receptor (GPCR) signal transduction. J Med Chem. 2011;54(21):7433–7440.21916427
   PubMed Web of Science ®Google Scholar
• Yamauchi Y, Miura Y, Kanaho Y. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs. Adv Biol Regul. 2017;63:115–121.27776975
   PubMedGoogle Scholar
• Zhang W, Qian S, Yang G, et al. MicroRNA-199 suppresses cell proliferation, migration and invasion by downregulating RGS17 in hepatocellular carcinoma. Gene. 2018;659:22–28.29559347
   PubMed Web of Science ®Google Scholar
• Zhu M, Guo J, Xia H, et al. Alpha-fetoprotein activates AKT/mTOR signaling to promote CXCR4 expression and migration of hepatoma cells. Oncoscience. 2015;2(1):59–70.25815363
   PubMedGoogle Scholar
• Tian P, Yan L. Inhibition of MicroRNA-149-5p induces apoptosis of acute myeloid leukemia cell line THP-1 by Targeting Fas Ligand (FASLG). Med Sci Monit. 2016;22:5116–5123.28013316
   PubMed Web of Science ®Google Scholar
• Jin L, Li Y, Liu J, et al. Tumor suppressor miR-149-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma. Mol Med Rep. 2016;13(6):5386–5392.27121091
   PubMed Web of Science ®Google Scholar
• Chen W, Zhang J, Xu H, Dai J, Zhang X. The negative regulation of miR-149-5p in melanoma cell survival and apoptosis by targeting LRIG2. Am J Transl Res. 2017;9(9):4331–4340.28979706
   PubMed Web of Science ®Google Scholar
• Ye X, Chen X. miR-149-5p inhibits cell proliferation and invasion through targeting GIT1 in medullary thyroid carcinoma. Oncol Lett. 2019;17(1):372–378.30655777
   PubMed Web of Science ®Google Scholar
• Wang AH, Fan WJ, Fu L, Wang XT. LncRNA PCAT-1 regulated cell proliferation, invasion, migration and apoptosis in colorectal cancer through targeting miR-149-5p. Eur Rev Med Pharmacol Sci. 2019;23(19):8310–8320.31646561
   PubMed Web of Science ®Google Scholar
• Jin L, Hu WL, Jiang CC, et al. MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma. Proc Natl Acad Sci U S A. 2011;108(38):15840–15845.21896753
   PubMed Web of Science ®Google Scholar
• Fan SJ, Li HB, Cui G, et al. miRNA-149* promotes cell proliferation and suppresses apoptosis by mediating JunB in T-cell acute lymphoblastic leukemia. Leuk Res. 2016;41:62–70.26725775
   PubMed Web of Science ®Google Scholar
• Chen D, Zhang M, Ruan J, et al. The long non-coding RNA HOXA11-AS promotes epithelial mesenchymal transition by sponging miR-149-3p in Colorectal Cancer. J Cancer. 2020;11(20):6050–6058.32922545
   PubMed Web of Science ®Google Scholar
• Shen Q, Zhu H, Lei Q, Chen L, Yang D, Sui W. MicroRNA‑149‑3p inhibits cell proliferation by targeting AKT2 in oral squamous cell carcinoma. Mol Med Rep. 2021;23:3.
   PubMed Web of Science ®Google Scholar
• Fujii T, Shimada K, Tatsumi Y, Fujimoto K, Konishi N. Syndecan-1 responsive microRNA-126 and 149 regulate cell proliferation in prostate cancer. Biochem Biophys Res Commun. 2015;456(1):183–189.25462564
   PubMedGoogle Scholar
• Chen Y, Zhao J, Luo Y, Wang Y, Jiang Y. Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line. Oncol Rep. 2016;36(5):2587–2600.27573045
   PubMed Web of Science ®Google Scholar
• Schaefer A, Jung M, Mollenkopf HJ, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2010;126(5):1166–1176.19676045
   PubMed Web of Science ®Google Scholar
• Mao H, Zhao Q, Daigle M, Ghahremani MH, Chidiac P, Albert PR. RGS17/RGSZ2, a novel regulator of Gi/o, Gz, and Gq signaling. J Biol Chem. 2004;279(25):26314–26322.15096504
   PubMed Web of Science ®Google Scholar
• Bar-Shavit R, Maoz M, Kancharla A, et al. G protein-coupled receptors in Cancer. Int J Mol Sci. 2016;17:8.
   Web of Science ®Google Scholar
• Li L, Luo HS. G-Protein Signaling Protein-17 (RGS17) is upregulated and promotes tumor growth and migration in human colorectal carcinoma. Oncol Res. 2018;26(1):27–35.28337960
   PubMed Web of Science ®Google Scholar
• James MA, Lu Y, Liu Y, Vikis HG, You M. RGS17, an overexpressed gene in human lung and prostate cancer, induces tumor cell proliferation through the cyclic AMP-PKA-CREB pathway. Cancer Res. 2009;69(5):2108–2116.19244110
   PubMed Web of Science ®Google Scholar
• Zhang LS, Ma HG, Sun FH, Zhao WC, Li G. MiR-203 inhibits the malignant behavior of prostate cancer cells by targeting RGS17. Eur Rev Med Pharmacol Sci. 2019;23(13):5667–5674.31298318
   PubMed Web of Science ®Google Scholar
• Rosenberg D, Groussin L, Jullian E, Perlemoine K, Bertagna X, Bertherat J. Role of the PKA-regulated transcription factor CREB in development and tumorigenesis of endocrine tissues. Ann N Y Acad Sci. 2002;968:65–74.12119268
   PubMed Web of Science ®Google Scholar